| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-12 11:45 Tx date 2025-11-12 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,100
+5,500 vol $0.20 each |
2,022,549 | |
| Filed 2025-10-14 16:47 Tx date 2025-10-14 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,515
+49,000 vol $0.235 each |
2,017,049 | |
| Filed 2025-08-28 13:10 Tx date 2025-08-28 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,800
+20,000 vol $0.24 each |
1,968,049 | |
| Filed 2025-08-28 13:09 Tx date 2025-08-28 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,350
+10,000 vol $0.235 each |
1,948,049 | |
| Filed 2025-08-15 11:09 Tx date 2025-08-15 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,965
+35,000 vol $0.199 each |
5,259,000 | |
| Filed 2025-08-13 11:05 Tx date 2025-08-13 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+10,000 vol $0.19 each |
1,938,049 | |
| Filed 2025-08-12 16:59 Tx date 2025-08-12 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,600
+40,000 vol $0.19 each |
1,928,049 | |
| Filed 2025-08-12 16:59 Tx date 2025-08-12 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,760
+20,000 vol $0.188 each |
1,888,049 | |
| Filed 2025-08-08 14:22 Tx date 2025-08-08 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+25,000 vol $0.18 each |
1,868,049 | |
| Filed 2025-08-08 14:21 Tx date 2025-08-08 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,625
+25,000 vol $0.185 each |
1,843,049 | |
| Filed 2025-08-06 15:37 Tx date 2025-08-06 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,250
+25,000 vol $0.17 each |
1,818,049 | |
| Filed 2025-08-01 11:52 Tx date 2025-08-01 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Germaine Matheson (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,800
+10,000 vol $0.18 each |
24,000 | |
| Filed 2025-08-01 11:52 Tx date 2025-07-29 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Germaine Matheson (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,240
+14,000 vol $0.16 each |
14,000 | |
| Filed 2025-08-01 11:51 Tx date 2021-06-14 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Germaine Matheson (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-08-01 11:43 Tx date 2025-08-01 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+25,000 vol $0.18 each |
1,793,049 | |
| Filed 2025-07-30 13:39 Tx date 2025-07-30 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,565
+35,000 vol $0.159 each |
1,768,049 | |
| Filed 2025-07-29 11:20 Tx date 2025-07-29 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$960.00
+6,000 vol $0.16 each |
1,733,049 | |
| Filed 2025-07-16 13:14 Tx date 2025-07-16 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,850
+10,000 vol $0.185 each |
1,727,049 | |
| Filed 2025-07-15 11:15 Tx date 2025-07-15 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,800
+20,000 vol $0.19 each |
1,717,049 | |
| Filed 2025-07-09 16:13 Tx date 2025-07-09 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,350
+55,000 vol $0.17 each |
1,697,049 |